ArticleCurrent therapeutic research, clinical and experimental2022
Modulation of Plasma 25-Hydroxyvitamin D3 Level by Imatinib Mesylate in Patients with Chronic Myelogenous Leukemia: The Role of Uptake and Efflux Transporters.
Mervat M Omran et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.